Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction

NCT02491008 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Dysfunction
Bone Mineral Density
Osteoporosis
Fractures, Bone

Interventions

DRUG: Levothyroxine
DRUG: Placebo

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]